These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15756735)

  • 41. Long-term treatment of adjunctive quetiapine for bipolar mania.
    Pae CU; Kim TS; Kim JJ; Lee SJ; Lee CU; Lee C; Paik IH
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):763-6. PubMed ID: 15951090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
    Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
    Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quetiapine in management of manic symptoms in patient with heart transplantation: a case report.
    Franić T; Kero T; Katić J; Marčinko D; Bilušić M
    Psychiatr Danub; 2012 Dec; 24(4):402-4. PubMed ID: 23132193
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical practice. Bipolar disorder--a focus on depression.
    Frye MA
    N Engl J Med; 2011 Jan; 364(1):51-9. PubMed ID: 21208108
    [No Abstract]   [Full Text] [Related]  

  • 45. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
    Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study.
    Pae CU; Nassir Ghaemi S; Patkar A; Chae JH; Bahk WM; Jun TY; Masand P
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1322-5. PubMed ID: 16631294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjunctive lamotrigine as a possible mania inducer in bipolar patients.
    Raskin S; Teitelbaum A; Zislin J; Durst R
    Am J Psychiatry; 2006 Jan; 163(1):159-60. PubMed ID: 16390907
    [No Abstract]   [Full Text] [Related]  

  • 49. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
    J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy.
    Janicak PG; Rado JT
    Expert Opin Pharmacother; 2012 Aug; 13(11):1645-52. PubMed ID: 22554110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initial and post-treatment total oxidant-antioxidant status and oxidative stress index in male patients with manic episode.
    Kalelioglu T; Genc A; Karamustafalioglu N; Tasdemir A; Can Gungor F; Cansiz A; Incir S; Cem Ilnem M; Emul M
    Psychiatry Res; 2014 Aug; 218(1-2):249-51. PubMed ID: 24768245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
    Shajahan P; Taylor M
    J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New treatments for bipolar disorder: the role of atypical neuroleptic agents.
    Ghaemi SN
    J Clin Psychiatry; 2000; 61 Suppl 14():33-42. PubMed ID: 11154015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atypical antipsychotics: newer options for mania and maintenance therapy.
    Vieta E; Goikolea JM
    Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychopharmacology news.
    Silva R
    J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):91. PubMed ID: 19232027
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic and pharmacological effects of second-generation antipsychotics on drug-resistant bipolar depression].
    Kuroki T; Kaminiwa S; Haeno M; Kohara K; Ninomiya H
    Seishin Shinkeigaku Zasshi; 2004; 106(8):1025-9. PubMed ID: 15655899
    [No Abstract]   [Full Text] [Related]  

  • 60. FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.
    Kuehn BM
    JAMA; 2009 Aug; 302(8):833-4. PubMed ID: 19706851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.